Search in:

Vascular Health and Risk Management Volume 10, 2014 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C – a cross-sectional study

Torsten Roed1 Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, DenmarkCorrespondence[email protected]

Ulrik Sloth Kristoffersen2 Department of Clinical Physiology, Nuclear Medicine and PET and Cluster for Molecular Imaging, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Andreas Knudsen1 Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark;2 Department of Clinical Physiology, Nuclear Medicine and PET and Cluster for Molecular Imaging, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Niels Wiinberg3 Department of Clinical Physiology, Frederiksberg Hospital, Copenhagen, Denmark

Anne-Mette Lebech1 Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark

Thomas Almdal4 Steno Diabetes Center, Copenhagen, Denmark

Reimar W Thomsen5 Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark

Andreas Kjær2 Department of Clinical Physiology, Nuclear Medicine and PET and Cluster for Molecular Imaging, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Nina Weis1 Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark;6 Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark

show all

Pages 55-62 | Published online: 21 Jan 2014

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (28)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (28)

Christina Sølund, Philip Hasbak, Andreas Knudsen, Andreas Kjaer, Anne M. Lebech & Nina Weis. (2022) Myocardial perfusion reserve in patients with chronic hepatitis C before and after direct‐acting antiviral treatment—a pilot study. Clinical Physiology and Functional Imaging 42:6, pages 389-395.
Crossref

Caitlin A. Moran, Lauren F. Collins, Nour Beydoun, Puja K. MehtaYetunde Fatade, Ijeoma IsiadinsoTené T. Lewis, Brittany Weber, Jill GoldsteinIgho OfotokunArshed Quyyumi, May Y. Choi, Kehmia TitanjiCecile D. Lahiri. (2022) Cardiovascular Implications of Immune Disorders in Women. Circulation Research 130:4, pages 593-610.
Crossref

Grazia PENNISI, Federica SPATOLA, Lorenza DI MARCO, Vincenzo DI MARTINO & Vito DI MARCO. (2021) Impact of direct-acting antivirals (DAAs) on cardiovascular diseases in patients with chronic hepatitis C. Minerva Gastroenterology 67:3.
Crossref

Dalia A Freekh, Maged W Helmy, Mohamed Said & Noha M El-khodary. (2021) The effect of direct acting antiviral agents on vascular endothelial function in Egyptian patients with chronic hepatitis C virus infection. Saudi Pharmaceutical Journal 29:10, pages 1120-1128.
Crossref

Hyun Yoon. (2021) The Relationship between the Serum Aspartate Aminotransferase/Alanine Aminotransferase Ratio and Pulse Pressure in Korean Adults with Hypertension. The Korean Journal of Clinical Laboratory Science 53:3, pages 241-248.
Crossref

Michael Broker, Shalom Z. Frager, Nayan S. Patel, Edward Lebovics & William H. Frishman. (2020) The Inflammatory Relationship Between Hepatitis C Virus With Coronary and Carotid Atherosclerosis. Cardiology in Review 29:4, pages 178-183.
Crossref

Riccardo NEVOLA, Carlo ACIERNO, Pia C. PAFUNDI & Luigi E. ADINOLFI. (2021) Chronic hepatitis C infection induces cardiovascular disease and type 2 diabetes: mechanisms and management. Minerva Medica 112:2.
Crossref

Ahmed Babiker, Mohamed Hassan, Safwan Muhammed, Gregory Taylor, Bhawna Poonia, Anoop Shah & Shashwatee Bagchi. (2019) Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review. Clinical Cardiology 43:3, pages 222-234.
Crossref

Rocío Muñoz-Hernández, Javier Ampuero, Raquel Millán, Antonio Gil-Gómez, Ángela Rojas, Hada C. Macher, Rocío Gallego-Durán, Sheila Gato, Rocío Montero-Vallejo, María C. Rico, Douglas Maya-Miles, Yolanda Sánchez-Torrijos, Isabel Carmona Soria, Pablo Stiefel & Manuel Romero-Gómez. (2020) Hepatitis C Virus Clearance by Direct-Acting Antivirals Agents Improves Endothelial Dysfunction and Subclinical Atherosclerosis: HEPCAR Study. Clinical and Translational Gastroenterology 11:8, pages e00203.
Crossref

Kuan Ken Lee, Dominik Stelzle, Rong Bing, Mohamed Anwar, Fiona Strachan, Sophia Bashir, David E Newby, Jasmit S Shah, Michael H Chung, Gerald S Bloomfield, Chris T Longenecker, Shashwatee Bagchi, Shyamasundaran Kottilil, Sarah Blach, Homie Razavi, Peter R Mills, Nicholas L Mills, David A McAllister & Anoop S V Shah. (2019) Global burden of atherosclerotic cardiovascular disease in people with hepatitis C virus infection: a systematic review, meta-analysis, and modelling study. The Lancet Gastroenterology & Hepatology 4:10, pages 794-804.
Crossref

V. Estrada & I. Sagastagoitia. (2019) Hepatitis C is a risk factor for cardiovascular disease. Revista Clínica Española (English Edition) 219:6, pages 322-323.
Crossref

V. Estrada & I. Sagastagoitia. (2019) La hepatitis C es un factor de riesgo para enfermedad cardiovascular. Revista Clínica Española 219:6, pages 322-323.
Crossref

Anupam Bapu Jena, Julia Thornton Snider, Oliver Diaz Espinosa, Andy Ingram, Yuri Sanchez Gonzalez & Darius Lakdawalla. (2019) How Does Treating Chronic Hepatitis C Affect Individuals in Need of Organ Transplants in the United Kingdom?. Value in Health 22:6, pages 669-676.
Crossref

Dan Wen, Xin Du, Jian-Zeng Dong & Chang-Sheng Ma. (2019) Hepatitis C virus infection and risk of coronary artery disease: A meta-analysis. European Journal of Internal Medicine 63, pages 69-73.
Crossref

Patrice Cacoub. (2019) Hepatitis C Virus Infection, a New Modifiable Cardiovascular Risk Factor. Gastroenterology 156:4, pages 862-864.
Crossref

Taciana Pereira Sant'Ana Santos, Mariana de Menezes Pereira, Maria Isabel Schinoni, Geraldo Pedral Sampaio, Roque ArasJr.Jr., Maria Luiza Sousa Atta & Ajax M. Atta. (2019) Atherogenic cytokines and chemokines in chronic hepatitis C are not associated with the presence of cardiovascular diseases. Cytokine 115, pages 24-31.
Crossref

Snehal R. Patel, Shivank Madan, Omar Saeed, Daniel B. Sims, J. Julia Shin, Cecilia Nucci, Edward Borukhov, Doctor Y. Goldstein, William Jakobleff, Stephen Forest, Sasa Vukelic, Sandhya Murthy, John Reinus, Yoram Puius, Daniel J. Goldstein & Ulrich P. Jorde. (2018) Cardiac transplantation from non-viremic hepatitis C donors. The Journal of Heart and Lung Transplantation 37:10, pages 1254-1260.
Crossref

Ahmed Babiker, Jean Jeudy, Seth Kligerman, Miriam Khambaty, Anoop Shah & Shashwatee Bagchi. (2017) Risk of Cardiovascular Disease Due to Chronic Hepatitis C Infection: A Review. Journal of Clinical and Translational Hepatology 5:4, pages 1-20.
Crossref

Alejandro Alvaro-Meca, Juan Berenguer, Asunción Díaz, Dariela Micheloud, Teresa Aldámiz-Echevarría, Chiara Fanciulli & Salvador Resino. (2017) Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy era. PLOS ONE 12:6, pages e0179493.
Crossref

M.F. Bassendine, S.U. Nielsen, S.H. Bridge, D.J. Felmlee, D.A. Sheridan, C.J. Packard & R.D. Neely. (2017) Hepatitis C virus and atherosclerosis: A legacy after virologic cure?. Clinics and Research in Hepatology and Gastroenterology 41:1, pages 25-30.
Crossref

Mitchell L. Shiffman & Nadege T. Gunn. (2017) Impact of hepatitis C virus therapy on metabolism and public health. Liver International 37, pages 13-18.
Crossref

O.O. Olubamwo, A.O. Aregbesola, J. Miettola, J. Kauhanen & T.-P. Tuomainen. (2016) Hepatitis C and risk of coronary atherosclerosis – A systematic review. Public Health 138, pages 12-25.
Crossref

Olubunmi O. Olubamwo, Ifeoma N. Onyeka, Juhani Miettola, Jussi Kauhanen & Tomi-Pekka Tuomainen. (2016) Hepatitis C as a risk factor for carotid atherosclerosis - a systematic review. Clinical Physiology and Functional Imaging 36:4, pages 249-260.
Crossref

Amira Abdel Moneam Adly, Nayera Hazaa El-Sherif, Eman Abdel Rahman Ismail, Yosra Abd El-Zaher, Amal Farouk, Asmaa Mohamed El-Refaey & Mohammed Samy Wahba. (2014) Vascular Dysfunction in Patients With Young β-Thalassemia. Clinical and Applied Thrombosis/Hemostasis 21:8, pages 733-744.
Crossref

X. Tong & P. R. Spradling. (2015) Increase in nonhepatic diagnoses among persons with hepatitis C hospitalized for any cause, United States, 2004-2011. Journal of Viral Hepatitis 22:11, pages 906-913.
Crossref

Vicente Soriano & Juan Berenguer. (2015) Extrahepatic comorbidities associated with hepatitis C virus in HIV-infected patients. Current Opinion in HIV and AIDS 10:5, pages 309-315.
Crossref

Francesco Negro. (2014) Facts and fictions of HCV and comorbidities: Steatosis, diabetes mellitus, and cardiovascular diseases. Journal of Hepatology 61:1, pages S69-S78.
Crossref

He Huang, Rongyan Kang & Zhendong Zhao. (2014) Is Hepatitis C Associated with Atherosclerotic Burden? A Systematic Review and Meta-Analysis. PLoS ONE 9:9, pages e106376.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C – a cross-sectional study

Articles from other publishers (28)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Increased prevalence of coronary artery disease risk markers in patients with chronic hepatitis C – a cross-sectional study

Citations (28)

Articles from other publishers (28)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date